Difference between revisions of "DIG5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
Line 16: | Line 16: | ||
!'''Date of Last Editor Review''' | !'''Date of Last Editor Review''' | ||
!'''Notes''' | !'''Notes''' | ||
+ | |- | ||
+ | |CHAPTER 2 (TUMOURS OF THE OESOPHAGUS) | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
|- | |- | ||
|[[DIG5:Oesophageal_squamous_papilloma|Oesophageal squamous papilloma]] | |[[DIG5:Oesophageal_squamous_papilloma|Oesophageal squamous papilloma]] | ||
Line 115: | Line 135: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 3 (TUMOURS OF THE STOMACH) | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
|- | |- | ||
|[[DIG5:Fundic_gland_polyps_|Fundic gland polyps]] | |[[DIG5:Fundic_gland_polyps_|Fundic gland polyps]] | ||
Line 259: | Line 299: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 4 (TUMOURS OF THE SMALL INTESTINE AND AMPULLA) |
− | + | | | |
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Non-ampullary_adenoma|Non-ampullary adenoma]] |
|Disease | |Disease | ||
| | | | ||
Line 281: | Line 330: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Ampullary_adenoma|Ampullary adenoma]] |
|Disease | |Disease | ||
| | | | ||
Line 292: | Line 341: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Non-ampullary_adenocarcinoma_|Non-ampullary adenocarcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 303: | Line 352: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Ampullary_adenocarcinoma_|Ampullary adenocarcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 314: | Line 363: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Small_intestinal_and_ampullary_neuroendocrine_neoplasms_|Small intestinal and ampullary neuroendocrine neoplasms]] |
|Disease | |Disease | ||
| | | | ||
Line 325: | Line 374: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 5 (TUMOURS OF THE APPENDIX) |
− | + | | | |
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Appendiceal_serrated_lesions_and_polyps|Appendiceal serrated lesions and polyps]] |
|Disease | |Disease | ||
| | | | ||
Line 347: | Line 405: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Appendiceal_mucinous_neoplasm_|Appendiceal mucinous neoplasm]] |
|Disease | |Disease | ||
| | | | ||
Line 358: | Line 416: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Appendiceal_adenocarcinoma|Appendiceal adenocarcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 369: | Line 427: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Appendiceal_goblet_cell_adenocarcinoma|Appendiceal goblet cell adenocarcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 380: | Line 438: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Appendiceal_neuroendocrine_neoplasms_|Appendiceal neuroendocrine neoplasms]] |
|Disease | |Disease | ||
| | | | ||
Line 391: | Line 449: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 6 (TUMOURS OF THE COLON AND RECTUM) |
− | + | | | |
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Colorectal_serrated_lesions_and_polyps|Colorectal serrated lesions and polyps]] |
|Disease | |Disease | ||
| | | | ||
Line 413: | Line 480: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Conventional_colorectal_adenoma_|Conventional colorectal adenoma]] |
|Disease | |Disease | ||
| | | | ||
Line 424: | Line 491: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Inflammatory_bowel_disease-associated_dysplasia_of_the_colorectum|Inflammatory bowel disease-associated dysplasia of the colorectum]] |
|Disease | |Disease | ||
| | | | ||
Line 435: | Line 502: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Colorectal_adenocarcinoma_|Colorectal adenocarcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 446: | Line 513: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Colorectal_neuroendocrine_neoplasms_|Colorectal neuroendocrine neoplasms]] |
|Disease | |Disease | ||
| | | | ||
Line 457: | Line 524: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 7 (TUMOURS OF THE ANAL CANAL) |
− | + | | | |
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Inflammatory_cloacogenic_polyp|Inflammatory cloacogenic polyp]] |
|Disease | |Disease | ||
| | | | ||
Line 479: | Line 555: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Anal_condyloma|Anal condyloma]] |
|Disease | |Disease | ||
| | | | ||
Line 490: | Line 566: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Anal_squamous_dysplasia_(intraepithelial_neoplasia)|Anal squamous dysplasia (intraepithelial neoplasia)]] |
|Disease | |Disease | ||
| | | | ||
Line 501: | Line 577: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Anal_squamous_cell_carcinoma|Anal squamous cell carcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 512: | Line 588: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Anal_adenocarcinoma|Anal adenocarcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 523: | Line 599: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Anal_neuroendocrine_neoplasms|Anal neuroendocrine neoplasms]] |
|Disease | |Disease | ||
| | | | ||
Line 534: | Line 610: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 8 (TUMOURS OF THE LIVER AND INTRAHEPATIC BILE DUCTS) |
− | + | | | |
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Focal_nodular_hyperplasia_of_the_liver|Focal nodular hyperplasia of the liver]] |
|Disease | |Disease | ||
| | | | ||
Line 556: | Line 641: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Hepatocellular_adenoma_|Hepatocellular adenoma]] |
|Disease | |Disease | ||
| | | | ||
Line 567: | Line 652: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Hepatocellular_carcinoma|Hepatocellular carcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 578: | Line 663: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Hepatoblastoma|Hepatoblastoma]] |
|Disease | |Disease | ||
| | | | ||
Line 589: | Line 674: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Bile_duct_adenoma|Bile duct adenoma]] |
|Disease | |Disease | ||
| | | | ||
Line 600: | Line 685: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Biliary_adenofibroma|Biliary adenofibroma]] |
|Disease | |Disease | ||
| | | | ||
Line 611: | Line 696: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Mucinous_cystic_neoplasm_of_the_liver_and_biliary_system|Mucinous cystic neoplasm of the liver and biliary system]] |
|Disease | |Disease | ||
| | | | ||
Line 622: | Line 707: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Intrahepatic_cholangiocarcinoma|Intrahepatic cholangiocarcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 633: | Line 718: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Combined_hepatocellular-cholangiocarcinoma_and_undifferentiated_primary_liver_carcinoma|Combined hepatocellular-cholangiocarcinoma and undifferentiated primary liver carcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 644: | Line 729: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Hepatic_neuroendocrine_neoplasms_|Hepatic neuroendocrine neoplasms]] |
|Disease | |Disease | ||
| | | | ||
Line 655: | Line 740: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 9 (TUMOURS OF THE GALLBLADDER AND EXTRAHEPATIC BILE DUCTS) |
− | + | | | |
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Pyloric_gland_adenoma_of_the_gallbladder|Pyloric gland adenoma of the gallbladder]] |
|Disease | |Disease | ||
| | | | ||
Line 677: | Line 771: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Biliary_intraepithelial_neoplasia_|Biliary intraepithelial neoplasia]] |
|Disease | |Disease | ||
| | | | ||
Line 688: | Line 782: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Intracholecystic_papillary_neoplasm_(formerly_Intracystic_/_intraductal_papillary_neoplasm)_|Intracholecystic papillary neoplasm (formerly Intracystic / intraductal papillary neoplasm)]] |
|Disease | |Disease | ||
| | | | ||
Line 699: | Line 793: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Intraductal_papillary_neoplasm_of_the_bile_ducts|Intraductal papillary neoplasm of the bile ducts]] |
|Disease | |Disease | ||
| | | | ||
Line 710: | Line 804: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Carcinoma_of_the_gallbladder|Carcinoma of the gallbladder]] |
|Disease | |Disease | ||
| | | | ||
Line 721: | Line 815: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Carcinoma_of_the_extrahepatic_bile_ducts|Carcinoma of the extrahepatic bile ducts]] |
|Disease | |Disease | ||
| | | | ||
Line 732: | Line 826: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Neuroendocrine_neoplasms_of_the_gallbladder_and_bile_ducts|Neuroendocrine neoplasms of the gallbladder and bile ducts]] |
|Disease | |Disease | ||
| | | | ||
Line 743: | Line 837: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 10 (TUMOURS OF THE PANCREAS) |
− | + | | | |
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Acinar_cystic_transformation_of_the_pancreas|Acinar cystic transformation of the pancreas]] |
|Disease | |Disease | ||
| | | | ||
Line 765: | Line 868: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Serous_neoplasms_of_the_pancreas|Serous neoplasms of the pancreas]] |
|Disease | |Disease | ||
| | | | ||
Line 776: | Line 879: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Pancreatic_intraepithelial_neoplasia_|Pancreatic intraepithelial neoplasia]] |
|Disease | |Disease | ||
| | | | ||
Line 787: | Line 890: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Pancreatic_intraductal_papillary_mucinous_neoplasm_|Pancreatic intraductal papillary mucinous neoplasm]] |
|Disease | |Disease | ||
| | | | ||
Line 798: | Line 901: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Pancreatic_intraductal_oncocytic_papillary_neoplasm_|Pancreatic intraductal oncocytic papillary neoplasm]] |
|Disease | |Disease | ||
| | | | ||
Line 809: | Line 912: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Pancreatic_intraductal_tubulopapillary_neoplasm_|Pancreatic intraductal tubulopapillary neoplasm]] |
|Disease | |Disease | ||
| | | | ||
Line 820: | Line 923: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Pancreatic_mucinous_cystic_neoplasm_|Pancreatic mucinous cystic neoplasm]] |
|Disease | |Disease | ||
| | | | ||
Line 831: | Line 934: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Pancreatic_ductal_adenocarcinoma|Pancreatic ductal adenocarcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 842: | Line 945: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Pancreatic_acinar_cell_carcinoma|Pancreatic acinar cell carcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 853: | Line 956: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Pancreatoblastoma|Pancreatoblastoma]] |
|Disease | |Disease | ||
| | | | ||
Line 864: | Line 967: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Solid_pseudopapillary_neoplasm_of_the_pancreas|Solid pseudopapillary neoplasm of the pancreas]] |
|Disease | |Disease | ||
| | | | ||
Line 875: | Line 978: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Non-functioning_pancreatic_neuroendocrine_tumours|Non-functioning pancreatic neuroendocrine tumours]] |
|Disease | |Disease | ||
| | | | ||
Line 886: | Line 989: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Insulinoma|Insulinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 897: | Line 1,000: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Gastrinoma|Gastrinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 908: | Line 1,011: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:VIPoma|VIPoma]] |
|Disease | |Disease | ||
| | | | ||
Line 919: | Line 1,022: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Glucagonoma|Glucagonoma]] |
|Disease | |Disease | ||
| | | | ||
Line 930: | Line 1,033: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Somatostatinoma|Somatostatinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 941: | Line 1,044: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:ACTH-producing_neuroendocrine_tumour|ACTH-producing neuroendocrine tumour]] |
|Disease | |Disease | ||
| | | | ||
Line 952: | Line 1,055: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Serotonin-producing_neuroendocrine_tumour|Serotonin-producing neuroendocrine tumour]] |
|Disease | |Disease | ||
| | | | ||
Line 963: | Line 1,066: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5:Indolent_T-cell_lymphoproliferative_disorder_of_the_GI_tract|Indolent T-cell lymphoproliferative disorder of the GI tract]] | + | |[[DIG5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]] |
− | |Disease | + | |Disease |
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[DIG5:Pancreatic_MiNENs|Pancreatic MiNENs]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 11 (HAEMATOLYMPHOID TUMOURS OF THE DIGESTIVE SYSTEM) | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | |- | ||
+ | |[[DIG5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)_involving_the_digestive_tract|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) involving the digestive tract]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[DIG5:Duodenal-type_follicular_lymphoma|Duodenal-type follicular lymphoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[DIG5:Enteropathy-associated_T-cell_lymphoma_|Enteropathy-associated T-cell lymphoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[DIG5:Monomorphic_epitheliotropic_intestinal_T-cell_lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[DIG5:Intestinal_T-cell_lymphoma_NOS|Intestinal T-cell lymphoma NOS]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[DIG5:Indolent_T-cell_lymphoproliferative_disorder_of_the_GI_tract|Indolent T-cell lymphoproliferative disorder of the GI tract]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[DIG5:Hepatosplenic_T-cell_lymphoma|Hepatosplenic T-cell lymphoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[DIG5:EBV+_inflammatory_follicular_dendritic_cell_sarcoma_of_the_digestive_tract|EBV+ inflammatory follicular dendritic cell sarcoma of the digestive tract]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[DIG5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[DIG5:Follicular_lymphoma|Follicular lymphoma]] | ||
+ | |Disease | ||
| | | | ||
| | | | ||
Line 974: | Line 1,218: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Mantle_cell_lymphoma_|Mantle cell lymphoma]] |
|Disease | |Disease | ||
| | | | ||
Line 985: | Line 1,229: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Burkitt_lymphoma|Burkitt lymphoma]] |
|Disease | |Disease | ||
| | | | ||
Line 996: | Line 1,240: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Plasmablastic_lymphoma|Plasmablastic lymphoma]] |
|Disease | |Disease | ||
| | | | ||
Line 1,007: | Line 1,251: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Posttransplant_lymphoproliferative_disorders|Posttransplant lymphoproliferative disorders]] |
|Disease | |Disease | ||
| | | | ||
Line 1,018: | Line 1,262: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Extranodal_NK/T-cell_lymphoma_|Extranodal NK/T-cell lymphoma]] |
|Disease | |Disease | ||
| | | | ||
Line 1,029: | Line 1,273: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Systemic_mastocytosis|Systemic mastocytosis]] |
|Disease | |Disease | ||
| | | | ||
Line 1,040: | Line 1,284: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]] |
|Disease | |Disease | ||
| | | | ||
Line 1,051: | Line 1,295: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]] |
|Disease | |Disease | ||
| | | | ||
Line 1,062: | Line 1,306: | ||
| | | | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Histiocytic_sarcoma|Histiocytic sarcoma]] |
|Disease | |Disease | ||
| | | | ||
Line 1,073: | Line 1,317: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 12 (MESENCHYMAL TUMOURS OF THE DIGESTIVE SYSTEM) |
− | + | | | |
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
| | | | ||
+ | ----<br /> | ||
|- | |- | ||
− | |[[DIG5: | + | |[[DIG5:Gastrointestinal_stromal_tumour_|Gastrointestinal stromal tumour]] |
|Disease | |Disease | ||
| | | | ||
Line 1,095: | Line 1,348: | ||
| | | | ||
|- | |- | ||
− | + | |[[DIG5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour]] | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |[[DIG5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour]] | ||
|Disease | |Disease | ||
| | | | ||
Line 1,402: | Line 1,622: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 13 (OTHER TUMOURS OF THE DIGESTIVE SYSTEM) | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
+ | | | ||
+ | ----<br /> | ||
|- | |- | ||
|[[DIG5:Mucosal_melanoma_of_the_digestive_system|Mucosal melanoma of the digestive system]] | |[[DIG5:Mucosal_melanoma_of_the_digestive_system|Mucosal melanoma of the digestive system]] |
Revision as of 11:04, 29 January 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.